Abstract. We have identified, characterized and cloned a novel mammalian myosin-I motor-molecule, called myr 1 (m__.~osin-I from _rat). Myr 1 exists in three alternative splice forms: myr la, myr lb, and myr lc. These splice forms differ in their numbers of putative calmodulin/light chain binding sites. Myr la-c were selectively released by ATP, bound in a nucleotidedependent manner to F-actin and exhibited amino acid sequences characteristic of myosin-I motor domains. In addition to the motor domain, they contained a regulatory domain with up to six putative calmodulin/light chain binding sites and a tail domain. The tail domain exhibited 47 % amino acid sequence identity to the brush border myosin-I tail domain, demonstrating that myr 1 is related to the only other mammalian myosin-I motor molecule that has been characterized so far. In contrast to brush border myosin-I which is expressed in mature enterocytes, myr 1 splice forms were differentially expressed in all tested tissues. Therefore, myr 1 is the first mammalian myosin-I motor molecule with a widespread tissue distribution in neonatal and adult tissues.
Abstract. We have identified, characterized and cloned a novel mammalian myosin-I motor-molecule, called myr 1 (m__.~osin-I from _rat). Myr 1 exists in three alternative splice forms: myr la, myr lb, and myr lc. These splice forms differ in their numbers of putative calmodulin/light chain binding sites. Myr la-c were selectively released by ATP, bound in a nucleotidedependent manner to F-actin and exhibited amino acid sequences characteristic of myosin-I motor domains. In addition to the motor domain, they contained a regulatory domain with up to six putative calmodulin/light chain binding sites and a tail domain. The tail domain exhibited 47 % amino acid sequence identity to the brush border myosin-I tail domain, demonstrating that myr 1 is related to the only other mammalian myosin-I motor molecule that has been characterized so far. In contrast to brush border myosin-I which is expressed in mature enterocytes, myr 1 splice forms were differentially expressed in all tested tissues. Therefore, myr 1 is the first mammalian myosin-I motor molecule with a widespread tissue distribution in neonatal and adult tissues.
The myr la splice form was preferentially expressed in neuronal tissues. Its expression was developmentally regulated during rat forebrain ontogeny and subcellular fractionation revealed an enrichment in purified growth cone particles, data consistent with a role for myr la in neuronal development.
M
YOSIN-IS differ from conventional muscle and non muscle myosins (myosin-I/s) by having only one heavy chain and a single motor domain (for review see 7, 24, 54) . The myosin-I motor domain is homologous to the motor domain of conventional myosin. This domain exhibits actin-activated Mg2+-ATPase activity and produces force along actin filaments (2, 25, 34, 64) . However, the heavy chain of myosin-I molecules lacks the extended u-helical tall domain of the conventional myosin heavy chain and is not capable of self-assembling into dimers and bipolar filaments. Instead, the tail domains of myosin-Is are thought to contain targeting signal(s) for membrane subdomains and to determine what kind of cargo is being moved. Several myosin-Is have been localized to specific membranous compartments within cells (3, 18, 43, 66) . Therefore, myosin-I motor molecules were proposed to move membranes along actin filaments. The movements of membranes powered by myosin-Is may include organelle movements (1, 36) and cell shape changes (17) .
Myosin-Is have been first discovered in the soil amoeba Acanthamoeba castellanii (29, 31, 39, 55) , and more recently several myosin-Is have been cloned from the slime mold Dictyostelium discoideum (30, 62) . The only well characterized vertebrate myosin-I is brush border myosin-I, originally known as ll0-kD calmodulin complex (10, 47) . Associated with its heavy chain are 3-4 calmodulin molecules as light chains. Brush border myosin-I forms lateral links between the plasma membrane and the actin bundle within the microvilli of intestinal brush border cells (12, 43) . The expression of brush border myosin-I is virtually restricted to intestinal brush border cells (19, 28) . Very recently, the purification of a myosin-I from bovine adrenal medulla and brain was reported (4) .
We hypothesized that myosin-I molecules play important roles in neuronal cells because actin-based cell motility is a fundamental prerequisite for neuronal development (46, 60) . Functional connections between nerve cells develop through extensive neuronal shape changes. Furthermore, the development of neuritic processes involves intense membrane trafficking between neuronal cell bodies and elongating axons and dendrites. Shape changes and membrane trafficking are functions in which protozoan myosin-Is have been implicated (1, 17) . Therefore, we probed the developing nervous system for the presence of myosin-I(s).
In this communication, we report on the identification of a novel mammalian myosin-I protein. To identify mammalian myosin-Is expressed in the developing nervous tissue, an antibody was generated against a synthetic peptide encompassing a conserved sequence of the (invertebrate) myosin-I motor domain which is sufficiently different from conventional myosin. Based on this myosin-I consensus antibody, we iden-tified, characterized and cloned myr la-c (first myosin I from _rat), a novel myosin-I from rat tissue. We provide evidence that myr la-c are related to brush border myosin-I, but serve functions not restricted to microvilli. Alternatively spliced 29 residue repeats in the regulatory domain may endow myr la-c with different regulatory properties. A partial and preliminary account of this work has been published in abstract form (B~ihler, M., 1990. J. Cell Biol. 111:167a).
Materials and Methods

Antibodies
To raise antibodies against a myosin-I consensus sequence, a 19 amino acid peptide was synthesized which duplicates the amino acid sequence YLGLLENVRVRRAGYAYRQ (611-629) of bovine brush border myosin-I (28) . A cysteine residue was added at the carboxy-terminus of the peptide for the selective coupling to a carder protein. The peptide was cross-linked with m-maleimidobenzoyl sulfosuccinimide ester (MBS; Pierce Chemical Co., Rockford, IL) to keyhole limpet hemocyanin (Calbiochem-Behring Co., San Diego, CA) as described by Green et al. (22) . Rabbits were injected intradermally or subcutaneously with 300 /tg coupled peptide emulsified in complete Freunds adjuvant (Gibco Laboratories, Eggenstein, FRG, and Sigma Co., Deisenhofim, FRG). For booster injections, 200/~g coupled peptide was emulsified in incomplete Freunds adjuvant. After two booster injections at 2-4 wk intervals, the rabbits were bled regularly. Peptide affinity columns were prepared by coupling the peptide to CNBractivated Sepharose 4B (Pharmacia, Freiburg, FRG) according to the instructions of the manufacturer. Antibodies were affinity purified by passing the sera over the peptide column and elntion with 0.2 M glycine, pH 2.8. An identical protocol was used for the generation and affinity purification of antibodies directed against the peptide derived myr 1 tail amino acid sequence (see Results) using the synthetic peptide NKNPKYKKLKDAIEEK-IIIAEVVNKINC (antisera TO 2) and the myr 1 NH2-terminus using the synthetic peptide MAKKEVKSSLLDNMC (antiscra TO 30) .
A monoclonal antibody (2.17) raised against cytoplasmic myosin-II from A. casteUanii recognizing the motor domain (33) and a polyclonal antibody raised in sheep against rat GAP-43 were generous gifts of Drs. T. D. Pollard (Johns Hopkins Medical School, Baltimore, MD) and L. I. Benowitz (Harvard Medical School, Boston, MA), respectively.
Extraction and Partial Purification of myr 1
Extraction ofmyr 1. To test the extractability of myr La, two frozen brains (-70~ from 2-d old rats were thawed and homogenized in 5 rni of 0.32 M sucrose, 5 mM Hepes pH 7.4 with a Dounce homogenizer. The homogenate was centrifuged in a TL-100 ultracentrifuge (Beckman Instruments, Palo Alto, CA) at 75,000 rpm for 15 rain (rotor TLA 100.2). Pellets were resuspended in 10 mM Hepes pH 7.4, 10 mM MgC12, and 100, 200, or 400 mM NaC1, respectively. To these samples was added either 5 mM ATE 15 mM CHAPS or nothing. One sample was extracted with 10 mM Hepes pH 7.4, 400 mM NaC1 and 10 mM Na-pyrophosphate. After centrifugation (75,000 rpm, 15 rain) supernatants were analyzed for extracted myr la by immunoblotting.
To test for ATP-dependent extractability of myr lb and lc, adult rat lung tissue was homogenized in a Dounce homogenizer in 0.32 M sucrose, 5 mM Hepes pH 7.4 and centrifuged at 16,000 rpm in a Sorvall SS34 rotor (DuPont-Nemours, Bad Homburg, FRG) for 20 rain. Pellets were resuspended in 0.1 M NaC1, 20 mM Hepes pH 7.4, 10 mM MgCI2, 1 mM 2-mercaptoethanol, 0.1 mM EGTA and 0.1% Triton X-100 (buffer A) and centrifuged in a TLA-100.4 rotor at 75,000 rpm for 20 min. Pellets were extracted in buffer A with or without the addition of ATP (5 m_M final concentration) and centrifuged as above. Supernatants were analyzed for the presence of myr lb and Ic by immunoblotting.
Partial Purification of myr la. Approximately 340 frozen rat brains (postnatal days 1-7) were homogenized in 500 ml of 0.32 M sucrose, 5 mM Hepes pH 7.4, and centrifuged in a Ti60 rotor at 50000 rpm for 1 h. The pellet was extracted with 100 mM NaC1, 10 mM MgC12, 10 mM Hepes pH 7.4 and centrifuged again. The resulting pellet was extracted two more times with the same buffer containing 5 mM ATP. The ATP-extracts were loaded onto a Mono Q (HR 5/5) column (Pharmacia) preequilibrated in 20 mM Hepes pH 7.4, 20 mM NaCI, 2 mM MgC12, 0.2 mM EDTA and 0.5 mM 2-mercaptoethanol. Applying a linear NaCI gradient (20 mM-1 M) myr fa ehited as a broad peak starting at 550 mM NaCI. Fractions containing myr la were pooled and dialyzed against 50 mM KC1, 10 mM Hepes pH 7.4 and 1 mM dithiothreitol. After dialysis, the sample was loaded onto a 5 ml ADP-agarose column (G1BCO BRL, Eggenstein, FRG) which had been preequilibrated in the dialysis buffer. The column was developed with a KCI gradient (50 raM-1 M) in a total volume of 40 ml, followed by a wash with a buffer containing 0.45 M NaCl, 20 mM Hepes pH 7.4, 50 mM KC1 and 1 mM dithiothreitol. Finally, myr la was eluted with the wash buffer supplemented with 20 mM MgCI2 and 10 mM ATE Throughout the purification the protease inhibitors PMSF (0.1 raM) and pepstatin (2 ~tg/ml) were included.
Partial Purification of myr lb and lc from Rat Liver. 50 g of frozen adult rat liver was homogenized in 200 ml of 0.32 M sucrose, 5 mM Hepes pH 7.4 and centrifuged in a SS34 rotor at 18,000 rpm for 30 rain. The resulting pellet was extracted with buffer B (320 mM NaCl, 20 mM Hepes pH 7.4, 10 mM MgC12, 1 mM 2-mercaptoethanol, 0.1 mM EGTA, and 2 mM NAN3) containing 0.1% Triton X-100 and was centrifuged in a Ti 50.2 rotor at 45,000 rpm for 1 h. The pellet was reextracted with buffer B before being extracted with buffer B supplemented with 5 mM ATE The ATP-extract was brought to 50% ammonium sulfate and the precipitate was collected, dissolved in a buffer (10 rni) of 50 mM KCI, 20 mM Hepes pH 7.4, 10 mM MgC12, 0.1 mM EGTA, 0.5 mM 2-mercaptoethanol and 2 mM NaN3 and dialyzed against the same buffer to yield an actomyosin pellet. The dialysate was centrifuged at 75,000 rpm for 30 rain (rotor TLA 100.4). The pellet was extracted twice in buffer C (0.5 M NaC1, 20 mM Hepes pH 7.4, 10 raM MgC12, 0.1 mM EGTA, 0.5 mM 2-mercaptoethanol, and 2 mM NAN3) supplemented with 10 mM ATP and centrifuged. The supernatants were combined and concentrated in a Centricon 30 (Amicon, Beverly, MA) before loading onto a Superdex 200 HiLoad (16/60) gel filtration column (Pharmacia) equilibrated in buffer C supplemented with 2 mM ATE Fractions containing myr lb and lc were pooled and dialyzed against low salt buffer (50 mM NaC1, 20 mM Hepes pH 7.4, 5 mM MgCI2, 0.1 mM EGTA, 0.5 raM 2-mereaptoethanol and 2 mM NAN3) supplemented with 1 ram ATP followed by chromatography over a Mono Q (HR5/5) ionexchange column (Pharmacia) equilibrated in the low salt buffer. Myr lb and lc were eluted with a NaCI gradient and tested for nucleotide-dependent binding to F-actin. All protein purification procedures were performed at 4~
Amino Acid Sequence Determination
Partially purified myr la was separated by SDS-PAGE and stained with Coomassie blue. The myr la protein band was excised, loaded onto a 10-20% gradient SDS-polyacrylamide gel and re-electrophoresed in the presence of S. aureus V8 protease (6/tg) as described by Cleveland et al. (9) . Digested proteins were electrophoretically transferred to Polyvinylidene difluoride immobilon membrane (Miilipore, Escbborn, FRG), stained and sequenced as described by Matsodaira (42), using an Applied Biosystems AB 470A gas-phase sequencer.
Actin Binding
Actin was purified from rabbit skeletal muscle as described by Pardee and Spudicb (51) . Actin was polymerized at 1 mg/ml in a buffer of 100 mM KC1, 2 mM MgCI2, 20 mM Hepes pH 7.4, 0.5 mM 2-mercaptoethanol and 2 mM NAN3. Actin binding assays were performed in total volumes of 100 #1 containing 5 #M actin. Fractions eluted from the Mono Q column enriched for myr la or myr lb and lc (see above) were added to the assay mixture. The assay buffer consisted of 20 mM Hepes pH 7.4, 2 mM MgCI2, 0.5 mM 2-mercaptoethanol, 0.4 mM NAN3, 20 cam KCI and ,~300-350 mM NaCl. Samples were incubated on ice for 20-30 rain. ATP (final concentration 2 mM) was added from a concentrated stock solution (0.1 M) 5 win before centrifugation. Supernatants and pellets were obtained after centrifugation (rotor TLA 100.2) at 75,000 rpm for 20 min and analyzed for myr 1 protein by immunoblotting and actin by Coomassie blue staining of SDS-gels, respectively.
Tissue Preparation and Subceilular Fractionation
Tissues were homogenized in 1% SDS, 1 mM 2-mercaptoethanol and prorein concentrations were determined by a modification (41) of the method of Lowry et al. (38) . Alternatively, they were homogenized in 0.32 M sucrose, 5 raM Hepes pH 7.4 and protein concentrations were determined by the method of Bradford (5) . Aliquots of the homogenates were immediately placed in SDS gel sample buffer (37) and boiled.
Growth cone fractions were very generous gifts of Drs. S. Helmke and K. Pfenninger (University of Colorado Health Sciences Center, Denver, CO) and were prepared as described (53) . A crude preparation of neuronal and glial cell bodies was prepared according to Sbaschnig-Agler et al. (58) and was also a gift of Drs. Helmke and Pfenninger.
Isolation ofa myr I cDNA-Probe by PCR Amplification
First strand eDNA was synthesized at 42~ using 1 ~g poly(A) + RNA purified from E19 embryonic rat brain tissue, superscript reverse transcriptase (GIBCO-BRL, Gaithersburg, MD) and random hexamer primers. After phenol/chloroform extraction and ethanol precipitation the eDNA was resuspended in 20 ~1 of H20 and stored at 4"C. PCR reactions in 50 #1 total volume included 2 tzl eDNA, PCR buffer (50 mM KCl, 3 mM MgC12, 100 #g/rnl gelatine and 10 mM Tris-HCl pH 8.3), 200/~M each of dATP, dGTP, dCTP, and dTTP, 25 U/ml Taq polymerase (Boehringer, Mannheim, FRG) and 100 pmol of the 32-fold degenerate primer MB16 (sense) 5'CAG-
AATTCCCICA(C/T)TA(C/T)ATI(C/T)GITG(C/T)ATIAA(A/G)CC
3', containing an EcoRI site and the 16-fold degenerate primer MB22 (antisense) 5' TCGGATCCGGCATI(C/T)(G/A)GAT(G/A)AT(C/T)TT 3' containing a BamHI restriction site. MBI6 was derived from the amino acid sequence PHYIRCIKP and MB22 from the amino acid sequence KIFIRME The reaction was cycled 40 times (94~ for 1 rain, 50~ for 1 rain and 72~ for 1 min). The amplified PCR products were separated on a 4% agarose gel (FMC Bioproduets, Rockland, ME; NuSieve GTG 3:1) and fragments of the expected size (318 bp) were isolated and purified using Qiaex Glassmilk (Diagen, Hilden, FRG). The purified fragments were cloned into a dT tailed pBluescript SK+ vector (Stratagene Corporation, La Jolla, CA) as described by Marchuk et al. (40) . Selected clones containing a 318 bp fragment were subjected to DNA sequencing. The oligonucleotides were synthesized using a Gene Assembler Plus DNA Synthesizer (Pharmacia, Milwaukee, WI).
PCR Amplification of the myr lc Isoform
"Ikvo PCR-primers corresponding to nucleotide 2237-2254 and nucleotide 2843-2863 of myr la which flank the region of divergence between myr la and myr lb were synthesized. Reactions were cycled 30 times (92~ for 1 rain, 620C for 1 rain and 72~ for 1 rain) using first-strand cDNA from rat kidney as template. The obtained PCR-fragments were cloned and sequenced as described above.
Library Screening A 1.2 kb cDNA clone was isolated from an embryonic (E18 rat brain) lambda gtl0 eDNA library (Clonetech, Palo Alto, CA) after screening with the myr 1 PCR fragment. This clone was used to screen a lambda Zap II eDNA library from adult rat brainstem/spinal cord tissue (Stratagene) and 12 positive clones were isolated out of 2 x 106 recombinants, pBlnescript SK plasmids were excised from lambda ZAP II clones according to the instructions of the supplier. The clones ZgA, Z7A, Z30A, Z39A, and Z34A were subjected to DNA sequencing.
DNA Sequencing
Nucleotide sequences were determined by the method of Sanger et al. (57) using double-stranded DNA templates and the USB scquenase version 2.0 kit (US Biochemicals, Cleveland, OH). For sequencing, a series of nested deletions were constructed by the method of Henikoff (27) with an Erase-abase kit (Promega Corp., Madison, WI). All sequences were determined for both strands. Nueleotide and amino acid sequences were analyzed with the PC/Gene (IntelliGenetics, Mountain View, CA) and the University of Wisconsin Genetics Computer Group (LrWGCG) (14; version 7) software packages. Sequence identities and similarities were determined using the UWGCG program GAP.
RNA Purification and Northern Blot Analysis
Total RNA was prepared according to the Method of Chirgwin et al. (8) and poly(A) + RNA was isolated using the PolyATract mRNA Isolation System (Promega Corp.). For northern blot analysis, poly(A) + RNA was electrophoresed in 1% agarose gels containing 2.2 M formaldehyde and transferred onto Hybond-N nylon membranes (Amersham, Braunschweig, FRG). The filters were prehybridized and hybridized at 42~ in 50% formamide, 5x SSC, 50 mM Na-phosphate pH 7, 0.5 % SDS, 0.1 mg/ml poly(A) and 0.25 mg/mt denatured salmon sperm DNA. DNA probes were labeled using a random primer labeling kit (Boehringer). Filters were washed (2x SSC, 0.1% SDS at RT, 2 x 30rain, 0.1x SSC, 0.1% SDS at 650C, 10 rain) and exposed to X-Omat AR film (Eastman Kodak Co., Rochester, NY) at -70"C with a Cronex Quanta III intensifying screen (Du Pont, Wilmington, DE).
Miscellaneous Techniques
Gel electrophoresis was performed according to Laemmli (37) and immunoblotting according to Towbin et al. (63) . For immunoblotting, primary antibodies were appropriately diluted in 5% nonfat dry milk and 0.1% Triton X-100 as blocking agents followed by 12~I-protein A (Amersham) or alkaline phosphatase conjugated secondary antibodies. Bound l~I-protein A was visualized by autoradiography using Kodak XAR-5 x-ray film and intensifying screens. Alkaline phosphatase was visualized by the ProtoBlot system (Promega Corp.). Calmodulin gel and blot overlays were performed as described by Slaughter and Means (59) . l~I-calmodulin was purchased from New England Nuclear (Dreieich, FRG).
Results
Identification of myr la with Antibodies Directed Against a Conserved Myosin-I Sequence
The rabbit polyclonal antiserum G-371 raised against the 18 amino acid synthetic peptide corresponding to amino acids 611-629 of bovine brush border myosin-l, a well conserved region among the sequenced myosin-Is, reacted with three major proteins of neonatal rat brain on immunoblots ( Fig.  1 a) . Their apparent molecular masses ranged from m90-130 kD. These molecular weights are well within the known molecular weight range of myosin-Is and above the minimal expected size of ,,080 kD corresponding to the size of the myosin motor domain. The protein with an apparent molecular mass of 130 kD was named myr la and further investigated.
Myr la is Selectively Released by ATP
Characteristic of myosin-I molecules is their selective extractability from tissue homogenates with ATP. Upon homogenization of neonatal rat brain tissues, myr la protein was present in the soluble and in the particulate fraction and was only released from the particulate fraction by the addition of ATP (Fig. 1 b) . High salt concentrations (400 mM NaCI) or detergent (15 mM CHAPS) were not sufficient to solubilize the protein. The addition of pyrophosphate, a compound which solubilizes protozoan myosin-Is efficiently (55), yielded a less efficient extraction of myr la. The selective extraction ofmyr la with ATP indicated that myr la could indeed represent a myosin-I molecule.
Myr la Binds in a Nucleotide-dependent Manner to F-Actin
A further characteristic of actin-based motor molecules is their nucleotide-dependent binding to F-actin. To test for nucleotide-dependent F-actin binding of the myr la protein, we partially purified the protein by ATP-extraction and Mono Q ion exchange chromatography (see Materials and Methods). The partially purified myr la sedimented together with F-actin in the absence of the nucleotide ATP, but not in the presence of ATP (Fig. 1 c) , as predicted for a myosin-I motor molecule.
Peptide Sequences Classify myr la as a Myosin-I
To obtain peptide sequence information for the myr la pro- Partially purified myr la from rat brain (see Materials and Methods) was incubated in the absence and presence (+) of actin (5 #M) and ATP (2 mM), respectively. The F-actin binding was assayed by cosedimentation with F-actin. Supernatants (s) and pellets (p) were analyzed for myr la protein by immunoblotting with the G-371 antibody.
tein, further purification of the protein was necessary. ADPagarose affinity purification and elution with ATP yielded a visible protein band on Coomassie blue stained SDS-gels (Fig. 2) . The major contaminants still present in the preparation were conventional myosin, actin and tubulin. After gel purification of myr la and cleavage with S. aureus protease V8, four internal peptide sequences were derived (see Fig.  5 ). The peptide sequences AFGNAKTVRNDNSSRFGK-YMDIEFDFKGDPL, FVDKNNDLLYRDLS, and FGR-SKIFIRNPRTLFQLE revealed a high homology to well conserved regions in the myosin-I motor domains. Furthermore, the peptide sequence NKNPKYKKLKDAIEEKII-IAEVVNKIN exhibited a significant homology to sequences in the brush border myosin-I tail domain (see Fig. 7 ). Taken together, these data strongly suggested that myr la is a member of the myosin-I superfamily.
Myr la Binds Calmodulin
Brush border myosin-I has been shown to bind calmodulin in gel overlay assays (20) . We therefore tested whether myr la was also able to bind calmodulin. Indeed, myr la did bind calmodulin both in the presence and absence of calcium ions (Fig. 2, lane 3 , and data not shown).
Myr la Expression is Regulated during Neuronal Development
We determined the developmental expression pattern of myr la in rat forebrain. As shown in Fig. 3 , myr la protein levels are regulated during rat forebrain development. The highest levels were found between embryonic day 17 and postnatal day 4 with a marked downregulation in the second week after birth. From there on, myr la levels stayed more or less constant during brain ontogeny.
Myr la Is Enriched in Purified Growth Cone Particles
To analyze the subcellular distribution of myr la in fetal rat brain, we probed subcellular fractions, specifically purified growth cone particles, for the presence of myr la (Fig. 4) . Myr la was significantly enriched in purified growth cone particles as compared to homogenate. In contrast, conventional myosin was clearly not enriched in purified growth cone particles (Fig. 4, lanes 1 and 5) . However, GAP-43, a protein known to be preferentially localized in growth cones (21, 44 ) was enriched to a greater extent than myr la in purified growth cone particles. When purified growth cone particles were further fractionated into a cytoskeletal fraction (detergent insoluble) and a detergent extractable fraction, myr la partitioned mainly into the cytoskeletal fraction, like myosin and to a lesser extent also GAP-43 (Fig. 4, lanes 6  and 7) . Myr la and GAP-43 both preferentially partitioned into fractions enriched in membranes (perykarya membrane fraction, low speed supernatant, growth cone particles) and they both were less enriched in a fraction rich in soluble proteins (A-fraction). This distribution was in marked contrast to the distribution of conventional myosin. These subcellular fractionation data showed that myr la was present in purified growth cone particles and was possibly associated with membranes.
Isolation and Analysis of myr I cDNA Clones Reveals Three Splice Forms
We identified cDNA clones corresponding to three alternative myr 1 splice forms, called myr la, myr lb, and myr lc. Clones for myr la (Z7A) and myr lb (Z9A) were isolated after screening a cDNA library from adult rat brainstem and (Fig. 5, arrowheads) . Sequence information of the third splice form, myr lc, was obtained after PCR amplification of rat kidney cDNA with myr 1 specific primers. The open reading frame of myr la-c started with an initiation sequence that was similar to the consensus initiation sequence described by Kozak (35) . Nucleotide sequences of the isolated myr 1 clones were identical, except for a short region of diversity between myr la-c. The deduced amino acid sequences of the myr 1 splice forms differed at amino acid 795 in that myr la contained three imperfect repeats of 29 amino acids, myr lb two imperfect repeats of 29 amino acids and myr lc a single copy of the 29 amino acid motif (Fig. 6) . In good agreement with the molecular masses determined by SDS-gels (130 kD for myr la), the calculated masses from the deduced amino acid sequences were 131,917 D for myr la (1,136 amino acids), 128,428 D for myr lb (1,107 amino acids) and 124,870 D for myr lc (1,078 amino acids), respectively. The isolated cDNA clones were encoding the four peptide sequences determined by direct amino acid sequencing of purified myr 1 protein (underlined amino acids in Fig.  5 ). These data demonstrated that the isolated cDNA clones were indeed encoding myr 1. Furthermore, the peptide sequence corresponding to the region recognized by the polyclonal antiserum G-371 was identified at position 618-636 of myr la-c (double underlined, Fig. 5 ).
Sequence Analysis and Structural Organization of myr 1
Analysis of the deduced myr lc amino acid sequence revealed an amino-terminal motor domain (amino acids 1-705), a regulatory domain with putative calmodulin/light chain binding 
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sites (amino acids 706-794) and a carboxy-terminal tail domain (amino acids 795-1078).
The Motor Domain. The amino-terminal motor domain exhibited a consensus ATP-binding site and sequences which are thought to be important for actin binding (Fig. 7) . A comparison of the myr 1 motor domain sequence with that of bovine brush border myosin-I indicated that these two domains are highly homologous (66% identity, 78 % similarity). With the exception of seven additional amino acids at the very amino terminus of myr 1, the two sequences were aligned without the introduction of gaps.
The Regulatory Domain. The regulatory domain consisted of multiple repeats of putative calmodulin/light chain binding motifs (Fig. 8) . Myr la-c contained up to six con- secutive repeats (amino acids 706-867) of the IQ-motif as defined by Cheney and Mooseker (7) (Fig. 8 A) . This motif has been shown to be responsible for the Ca2+-independent calmodulin binding of the nonmyosin protein neuromodulin (6). Three consecutive repeats of this IQ-motif had previously been identified in brush border myosin-I (7, 61). These three brush border myosin-I repeats shared an identity of 60% (80% similarity) with the first three repeats in myr 1. As in brush border myosin-I, the second repeat in myr I was the least similar to the IQ-consensus sequence.
Partially overlapping with the sequence (amino acids 766-774) of the third IQ-motif repeat, the myr 1 regulatory domain contained variable numbers of imperfect 29 residue repeats. These repeats were also fitted into the IQ-motif (Fig.  8 A) . However, the relation of these repeats to the IQ-motif seemed uncertain, because highly conserved residues of the IQ-motif, like the glutamine (Q) residue and the arginine (R) residue following three residues after the conserved glutamine residue were not conserved in these repeats. These 29 residue repeats were present in one constitutive and two alternatively spliced variants. Individual pairwise comparison of these amino acid repeats revealed 72 % identity between the two facultative 29 amino acid repeats (amino acids 795-823 and 824-852) and '~41% between the constitutive (amino acids 766-794) and each of the two facultative 29 amino acid repeats. A 29 amino acid alternative splice insert with a similar sequence (55 % identity to the constitutive myr 1 repeat) has been reported for a low abundance isoform of chicken brush border myosin-I (23) (Fig. 8 B) . All four of these 29 amino acid repeats fit the motif with the consensus sequence XRBXXBXL *WXGXX (B, basic residue; #, hydrophobic residue; * aromatic residue) (Fig. 8 B) . A synthetic peptide corresponding to the chicken brush border myosin-I alternative splice insert sequence has been demonstrated to bind calmodulin (23). Therefore, the 29 amino acid repeats found in myr 1 are likely to be involved in calmodulin/light chain binding. The three alternative splice forms of myr 1 differed in their numbers of 29 amino acid repeats. In total, myr la contained six, myr lb five and myr lc four putative calmodulin/light chain binding sites.
The Tail Domain. The carboxy-terminal tail domain of myr la (~-,33 kD) which followed the variable regulatory domain was identical in all three splice forms. Like the tail domains of other myosin-I molecules, the myr 1 tail domain exhibited a high number of basic residues (,',,20%). Specific functions of myosin-I molecules were thought to depend on their individual tail domains. Therefore, it was of particular interest that the tail domain of myr 1 shared significant homology with the tail domain of bovine brush border myosin-I. In this carboxy-terminal domain, 46% of the amino acids (23) . The derived 29 residue motif consensus sequence is shown below the alignment. Capital letters indicate conserved residues, + indicate conserved basic residues, * conserved aromatic residues, and # conserved hydrophobic residues. Conserved amino acids are printed in bold type.
were identical (67 % were similar with the introduction of a single gap of one residue) with the analogous domain in bovine brush border myosin-I. This homology was lower as compared to the homologies found in the motor domain and the overlapping regions of the regulatory domain, but clearly indicated that myr 1 and brush border myosin-I are related proteins.
Expression of myr I mRNA in Various 7issues
Northern blot analysis of poly(A) + RNA from adult ( Fig. 9  A) and neonatal ( Fig. 9 B) rat tissues revealed that myr 1 was expressed in most of the investigated tissues. A broad band with an apparent size range of 5.7-6.2 kb was strongly labeled in adult lung, but was barely detectable in adult intestine. Expression of myr 1 was detected in all of the investigated neonatal tissues. Remarkably high levels of transcripts were observed in neonatal brain and lung tissues. In striking contrast to the preferential expression of brush border myosin-I in intestine (19, 32) , northern blot data indicated a widespread tissue distribution of myr 1. A faint band of unknown origin below the main band was also detected.
Differential Expression of myr I a-c
In agreement with the identification of three myr 1 splice forms by cDNA cloning, we detected three closely spaced protein bands upon immunoblotting with myr 1 specific antibodies (Fig. 10) . Several antisera specific for myr 1 were raised (see Materials and Methods and unpublished results). All of these antisera recognized strongly the identical 130-kD protein band in embryonic rat brain originally identified by the consensus myosin-I antibody G-371. The 130-kD protein band was the slowest migrating band observed in any tissue. Because the apparent molecular mass coincided with the deduced molecular weight of myr la, we refer to this band as myr la. In adult brain regions we observed an additional band running slightly ahead of myr la with an apparent molecular mass expected for myr lb. The detection of myr la and myr lb in brainstem ( Fig. 10 ) is in excellent agreement with the cloning of myr la and myr lb out of a brainstem cDNA library. A third, again slightly faster migrating immunostained protein band was apparent in many tissues but was most prominent in lung tissue (Fig. 10) . Because the a ~_~_ myr lb myr lc molecular mass of this band coincided with the predicted molecular weight for myr lc and because we detected no additional bands by immunoblotting, we refer to it as myr lc. Myr 1 a-c were differentially expressed in the various tested tissues. Myr la was most prominently expressed in embryonic brain tissue (see for comparison also Fig. 3 ) and in adult tissues of the various brain regions and in testis. Myr lb and lc were most prominently expressed in lung and liver. Lower levels of myr lb and lc were observed in many other tissues including intestine (Fig. 10, and data not shown) . The identical three protein bands were also recognized by the myosin-I consensus antibody G-371 as demonstrated by probing proteins specifically immunoprecipitated with the myr 1 specific antibody Tii 2.
Great care was taken to avoid any proteolysis by directly placing the excised tissues in 1% SDS and boiling of the tissues. Furthermore, after longer storage protein degradation could indeed be observed, but always yielded breakdown products with substantially lower apparent molecular masses (see, e.g., Figs. 2 and 11) . A tissue dependent differential myr 1 breakdown also seemed extremely unlikely. And finally, the identification of three closely spaced bands was in excellent agreement with the identification of three myr 1 splice forms by eDNA cloning techniques. However, to even further verify that the bands we refer to as myr lb and myr lc behaved like myr la, we tested whether these proteins are selectively released by ATP and whether they bind in an ATP-dependent manner to F-actin. As shown in Fig. 11 a, myr lb and lc were selectively released by ATP from lung tissue particulate fractions. We partially purified myr lb and lc from rat liver as described in Materials and Methods and tested the two proteins for nucleotide-dependent F-actin binding. Both myr lb and myr lc cosedimented with F-actin in the absence of ATP, but not in the presence of ATP (Fig.  11 b) , demonstrating nueleotide-dependent binding to F-actin. Nucleotide-dependent binding of myr lb and lc from rat liver to F-actin. The myr lb, lc protein doublet recognized by the Tti 2 antibody in rat liver was partially purified as described in Materials and Methods and incubated in the absence or presence (+) of actin (5 #M) and ATP (2 mM). The F-actin binding was assayed by cosedimentation with F-actin. Supernatants (s) and pellets (p) were analyzed for myr lb and lc proteins by immunoblotting with the Tfi 2 antibody. Molecular weight standard in kD is shown on the right. Breakdown products of myr lb and lc are also apparent. Myr lb and lc are marked on the left.
Discussion
In the present study we describe the identification, characterization and cloning of a mammalian myosin-I, myr la-c, which exhibits a remarkable similarity to the brush border myosin-I. The identification was based on an antibody raised against a synthetic peptide with a highly conserved sequence specific for myosin-Is, however, sufficiently different from conventional myosins. The sequence spans the myosin-I sequence analogous to the flexible, exposed region of the SH2-SH1 reactive thiols of conventional myosins. The antibody as described in this report might be of general use for the identification of novel myosin-Is (BElaler, M., 1990. Z Cell Biol. 111:167a; Behrmann, T., C. Ruppert, R. Kroschewski, S. Kieferle and M. B~hler. 1992. Fur. J. Cell Biol. 57: 8 (Suppl. 36). Because modification of SH2 and SH1 reactive thiols in conventional myosins interferes with motor function (for review 49, 65) , the antibody might also be of value for studying myosin-I motor function.
Amino acid sequence comparison revealed that rat myr 1 shares a remarkable homology with both the head and tail domains of bovine and chicken brush border myosin-Is. However, as opposed to brush border myosin-I which is expressed predominantly in intestine (19, 32) , myr 1 was expressed in a variety of neonatal and adult tissues and was barely detectable in adult intestine. Myr 1 was most abundant in lung, liver and brain and the expression pattern was not correlated with the abundance of microvilli. Furthermore, myr 1 was found to exist in at least three isoforms which most likely arise by differential splicing.
The existence of a brush border myosin-I multigene family had been suggested based on Southern blot data obtained with a bovine brush border myosin-I probe (28) . In addition, antibodies raised against brush border myosin-I were found to react with a 135-kD calmodulin-binding protein from rat fetal brush borders (56), a 130-kD protein from mouse F9 teratocarcinoma cells (15) , a 130-and a 140-kD protein from human intestinal cell lines (52) and a 150-kD protein from mouse brain (45) . The relationships of these immunogens to myr 1 remain to be determined. Very recently, the purification of a ll6-kD myosin-I from bovine adrenal gland and brain with similarities to brush border myosin-I has been described (4). However, the reported bovine 116-kD myosin-I peptide sequences make it very unlikely that this protein is identical to rat myr 1. The mentioned observations raise the possibility that there exists a larger family of brush border type myosin-Is.
Motor activity, calmodulin-binding and lipid-binding have been analyzed in some detail for brush border myosin-I (I1, 26, 48, 61) . Based on the sequence similarity of myr 1 with brush border myosin-I, it can be postulated that myr 1 shares many properties with brush border myosin-I. We have demonstrated that myr 1 is extracted from tissue homogenates by ATP, that it binds in a nucleotide-dependent manner to F-actin and that it binds calmodulin. It remains to be shown whether myr 1 exhibits actin-activated ATPase activity which is regulated by Ca2+/calmodulin and whether myr 1 binds to negatively charged phospholipids and membranes.
To address the functions of brush border myosin-I, Coudrier et al. (13) expressed the tail domain of chicken brush border myosin-I in cell lines. Interestingly, the brush border myosin-I tail localized in cells without microvilli to organelles and disrupted the Golgi-complex suggesting a role in membrane trafficking. It will be interesting to determine whether overexpression of the brush border myosin-I tail interferes with the function of myr 1.
We have demonstrated that myr la can bind calmodulin and therefore myr 1 function is likely to be regulated by CaE+/calmodulin. Three repeats of a Ca2+-independent calmodulin binding motif (IQ-motif, 7) were detected in myr 1. Overlapping with the third repeat was a second putative calmodulin/light chain binding motif, the 29 residue motif. Myr 1 splice forms differ in their numbers of the 29 residue motif in the regulatory domain. This motif shares a considerable homology with a 29 residue insert at the analogous position in chicken brush border myosin-I (23). Interestingly, a synthetic peptide of the brush border myosin-I insert sequence has been demonstrated to bind calmodulin (23) . Therefore, the variable numbers of 29 residue repeats in myr 1 might lead to different numbers of calmodulin/light chain binding sites. The 29 residue motif does not fit well into the IQ-motif which binds calmodulin in the absence of Ca 2+. However, the 29 residue motif does also not conform to the highly basic amphipathic or-helix motif for calcium-dependent calmodulin binding sites (50) . It contains a high number of basic and hydrophobic residues which are predicted to form a helical secondary structure. Further studies are needed to clarify whether this motif is a calmodulin/light chain binding site. Whatever the precise role of the 29 residue motif will turn out to be, it seems likely that this motif serves a regulatory function. Several calmodulin-binding sequences have also been shown to bind to phospholipid vesicles (16, 61) making the calmodulin/light chain binding motifs possible mediators between motor activity and cargo interaction.
Myr 1 is the first myosin-I motor molecule with a widespread distribution in neonatal and adult tissues. Individual members of myr 1 exhibited a tissue and developmentally regulated expression. Myr la was most prominently expressed in the developing nervous tissue. Furthermore, upon subceUular fractionation of fetal rat brain, myr la was found to be enriched in purified growth cone particles. Although the relative enrichment was lower than for GAP-43, an axonal growth cone marker protein (21, 44) , this result does provide evidence for the presence of myr la in growth cones. Myr la might possibly be associated with a membranous structure since purified growth cone particles are enriched in membranous structures (53) . However, in situ immunolocalization studies are required to determine its exact localization.
Myr lb and lc were predominantly expressed in adult nonneuronal tissues, e.g., lung and liver. The differential expression of the myr 1 splice forms could provide a specific means of adaptation to a particular cellular environment since they differ only in their numbers of putative calmodulin/light chain binding sites.
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